Now live: Innocentive Marketplace. Get shortlisted for funded opportunities today.
Innovation Showcase

AstraZeneca

AstraZeneca is a Global Biopharmaceutical Company with Research and Development at its Core.

View our latest Challenges

AstraZeneca is a Global Biopharmaceutical Company with Research and Development at its Core. The global healthcare environment is changing at a rapid pace. Healthcare is becoming more personalized, treatments are becoming more targeted, and economic pressures mean governments and healthcare systems are demanding increasingly cost-effective solutions to healthcare problems. Our ultimate mission is to make a difference through our medicines for patients, their families and society in general. We believe that scientific research is the key to achieving this, in collaboration with others who share our interest and our passion.

View the latest AstraZeneca Challenges

Our Open Innovation Goals and Resources Available

Although AstraZeneca has extensive expertise in biopharmaceutical research and development, we recognize that great ideas come from many sources. In fact, most biomedical innovation occurs outside company walls. Thus, we believe that we stand a much better chance of delivering meaningful treatments for serious diseases like Alzheimer’s, cancer and diabetes if we collaborate and share knowledge and resources with other scientists and organizations rather than work in isolation.

You are invited to view and participate in our Challenges, please click on the Challenges tab for more information. In addition to the open innovation Challenges, we are seeking to collaborate with partners across all stages of drug discovery – from the early idea through to early clinical development. These partnerships could profit from the exchange of compounds, technology and/or knowledge to provide an extra gear to hasten and augment the research. For our partners and collaborators, working with AstraZeneca means access to optimized compounds, compound libraries, technologies, multi-disciplinary science, services and know-how, with the prospect of joint publications in high profile journals and, most importantly, the opportunity to see their ideas develop into treatments for patients.

What Challenge will you solve today?

Collaboration Update

In 2011, a novel agreement between the Medical Research Council (MRC) and AstraZeneca gave academic researchers across the UK unprecedented access to 22 of our clinical and preclinical compounds.
Visit AstraZeneca to learn more

Our ultimate mission is to make a difference through our medicines for patients, their families and society in general. We believe that scientific research is the key to achieving this, in collaboration with others who share our interest and our passion.

Industry

Pharmaceuticals

Headquarters

UK

Total Challenges Run

28

Visit the Challenge Homepage to view all open Challenges

New to Innocentive? Learn more about Challenges and how to Become a Solver

How does the Challenge process work?

Follow these steps to participate in Innocentive challenges and potentially win awards.

1

Register as a Solver

To register for a Solver account and join Innocentive:

  • Go to the Innocentive Challenge Center registration page.
  • Enter an email address, which will be used to login to your account.
  • Complete the remaining required fields including: (1) Name, (2) Display Name and (3) Location.
  • Create a password. You will be guided to ensure you create a strong password to protect your account.
  • Click the Register button.
  • After you complete the registration form, you will receive an email notification confirming your registration and containing instructions to activate your account.
  • Click the link in the email. You will be asked to accept the Innocentive Terms of Use to complete the account activation process.
2

Review the Challenge Agreement

The Challenge Agreement (formerly Challenge Specific Agreement or CSA) is a legal document that outlines a Solver's rights and responsibilities if they elect to submit a solution in response to an Innocentive Challenge. The Challenge Agreement specifies if and how IP will be transferred between Solver and Seeker; it may also specify any special rules, such as exclusionary rules for categories of Solvers, that apply to the Challenge.

You must accept the Challenge Agreement to be able to submit a solution to the Challenge. Be sure to read and understand the Challenge Agreement for each Challenge because you will be subject to the applicable Challenge conditions.

Challenge Agreements provide Solvers with clear details around participation, legal IP transfer (if applicable), and details around Prize and Scouting Challenges.

3

Submit a Solution

To submit a Solution to an Innocentive Challenge as a member of the Solver community:

  1. Go to the Innocentive Challenge Center.
  2. Select a Challenge.
  3. Click Register Interest & Accept Agreement.
  4. Agree to the Challenge Agreement.
  5. Click Add Solution.
  6. Enter any required information.
  7. Attach your solution files.
  8. Click Publish.

You will receive an email confirmation of receipt of your solution to your registered email address.

4

Win

Receive cash awards or collaboration agreements if your solution or proposal is accepted by Seeker organizations.

Your solution will be evaluated following the due date for submissions. You will then be notified via email as to whether your solution has been successful. In some challenges, you will also receive feedback on your submission.

Award Potential

We've awarded more than $60 million to thousands of Solvers from around the world.

The average award amount is approximately $20,000, but some challenges come with awards of over $100,000 or collaboration agreements.